Abiopharma

CALUMET, INC. /DE (CLMT)

Symbol	CLMT
Name	CALUMET, INC. /DE
Sector	ENERGY
Region	North America
Industry	Petroleum Refining
Address	1060 N CAPITOL AVE, INDIANAPOLIS, IN 46204
Telephone	(317) 328-5660
Fax	—
Email	—
Website	https://www.calumet.com
Incorporation	UNDEFINED
Incorporated On	—
Employees	—
Fiscal Year	—
Public Since	—
Exchanges	NASDAQ
Auditor	—
Audit Status	NOT PROVIDED
Reporting Status	—
CIK	0002013745
Description	Calumet Specialty Products Partners LP is an independent producer of specialty hydrocarbon products in North America. The company operates through three segments namely Specialty Products and Solutions segment manufacture and market solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and other products. In Performance Brands segment, the company blend, package and market high performance products through its Royal Purple, Bel-Ray, and TruFuel brands. The Montana/Renewables segment is comprised of two businesses - renewable diesel and specialty asphalt. The Corporate segment primarily consists of general and administrative expenses not allocated to the Specialty Products and Solutions, Performance Brands or Montana/Renewables segments. Additional info from NASDAQ: Calumet Specialty Products Partners LP is an independent producer of specialty hydrocarbon products in North America. The company operates through three segments namely Specialty Products and Solutions segment manufacture and market solvents, waxes, customized lubricating oils, white oils, petrolatums, gels, esters, and other products. In Performance Brands segment, the company blend, package and market high performance products through its Royal Purple, Bel-Ray, and TruFuel brands. The Montana/Renewables segment is comprised of two businesses - renewable diesel and specialty asphalt. The Corporate segment primarily consists of general and administrative expenses not allocated to the Specialty Products and Solutions, Performance Brands or Montana/Renewables segments.

2026-07-23 11:00

Calumet, Inc. to Release Second Quarter 2026 Earnings on August 7, 2026

2026-07-02 21:27

Director Sajkowski Daniel J 🔴 sold 4.2K shares of Calumet, Inc. /DE (CLMT) at $36.16 Transaction Date: Jul 01, 2026 | Filing ID: 047050

2026-06-05 18:00

New Form SCHEDULE 13D/A - Calumet, Inc. /DE Filed: 2026-06-05 AccNo: 0001193125-26-259859 Size: 130 KB

2026-06-04 22:55

SANDERS BRADFORD TIMOTHY 🟢 acquired 3.5K shares (1 derivative) of Calumet, Inc. /DE (CLMT) Transaction Date: Jun 02, 2026 | Filing ID: 000004

2026-06-04 20:31

Raymond Paul C 🟢 acquired 3.5K shares (1 derivative) of Calumet, Inc. /DE (CLMT) Transaction Date: Jun 02, 2026 | Filing ID: 000003

2026-06-04 20:28

Twitchell Karen A. 🟢 acquired 3.5K shares (1 derivative) of Calumet, Inc. /DE (CLMT) Transaction Date: Jun 02, 2026 | Filing ID: 000001

2026-06-04 20:27

Boss John G. 🟢 acquired 3.5K shares (1 derivative) of Calumet, Inc. /DE (CLMT) Transaction Date: Jun 02, 2026 | Filing ID: 000003

2026-06-04 20:26

Quintana Julio M 🟢 acquired 3.5K shares (1 derivative) of Calumet, Inc. /DE (CLMT) Transaction Date: Jun 02, 2026 | Filing ID: 000003

2026-06-04 20:25

Mawer Stephen P 🟢 acquired 6.1K shares (1 derivative) of Calumet, Inc. /DE (CLMT) Transaction Date: Jun 02, 2026 | Filing ID: 000004

2026-06-04 20:23

Schumacher Amy M 🟢 acquired 3.5K shares (1 derivative) of Calumet, Inc. /DE (CLMT) Transaction Date: Jun 02, 2026 | Filing ID: 000004